cinnabsin 25 mg/1 tableta+ 25 mg/1 tableta+ 25 mg/1 tableta+ 25 mg/1 tableta tableta
alpen pharma d.o.o. - Трит cinnabaris. d3, Трит echinacea. Д1, Трит hydrastis. d3, Трит koristi se za prikaz preostalih kalija. d3 - tableta - 25 mg/1 tableta+ 25 mg/1 tableta+ 25 mg/1 tableta+ 25 mg/1 tableta - jedna tableta sadrži: 25 mg cinnabaris trit.d3 25 mg hydrastis trit. d3 25 mg kalium bichromicum trit. d3 25 mg echinacea trit. d1
chromid tm carba smart agar (carb/oxa)
a&b d.o.o. art 10000 zagreb -
trepulmix
scipharm sàrl - treprostinil natrija - hipertenzija, plućna - antitrombotska sredstva - treatment of adult patients with who functional class (fc) iii or iv and:inoperable chronic thromboembolic pulmonary hypertension (cteph), orpersistent or recurrent cteph after surgical treatmentto improve exercise capacity.
blazer cobalt chromium stent
sonimed d.o.o., zagreb - stent koji se primjenjuje kod koronarne balonske angioplastike kako bi održao prohodnost krvnih žila
rebel monorail platinum chromium coronary stent system
medical intertrade d.o.o. dr. franje tuđmana 3 10431 sveta nedelja -
imbruvica
janssen-cilag international nv - ibrutinib - lymphoma, mantle-cell; leukemia, lymphocytic, chronic, b-cell - antineoplastic agents, protein kinase inhibitors - imbruvica as a single agent is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (mcl). imbruvica as a single agent or in combination with rituximab or obinutuzumab or venetoclax is indicated for the treatment of adult patients with previously untreated chronic lymphocytic leukaemia (cll) (see section 5. imbruvica as a single agent or in combination with bendamustine and rituximab (br) is indicated for the treatment of adult patients with cll who have received at least one prior therapy. imbruvica as a single agent is indicated for the treatment of adult patients with waldenström’s macroglobulinaemia (wm) who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo immunotherapy. imbruvica in combination with rituximab is indicated for the treatment of adult patients with wm.
vaxcel chronic dialyss kateter
boston medical d.o.o., zagreb - trajni kateter za dijalizu kroničnih nefroloških bolesnika
vafseo
akebia europe limited - vadadustat - renal insufficiency, chronic; anemia - antianemijski pripravci - vafseo is indicated for the treatment of symptomatic anaemia associated with chronic kidney disease (ckd) in adults on chronic maintenance dialysis.
pegasys
pharmaand gmbh - peginterferon alfa-2a - hepatitis c, chronic; hepatitis b, chronic - Иммуностимуляторы, - chronic hepatitis b adult patients pegasys is indicated for the treatment of hepatitis b envelope antigen (hbeag)-positive or hbeag-negative chronic hepatitis b (chb) in adult patients with compensated liver disease and evidence of viral replication, increased alanine aminotransferase (alt) and histologically verified liver inflammation and/or fibrosis (see sections 4. 4 i 5. paediatric patients 3 years of age and older pegasys is indicated for the treatment of hbeag-positive chb in non-cirrhotic children and adolescents 3 years of age and older with evidence of viral replication and persistently elevated serum alt levels. s poštovanjem za rješavanje započeti liječenje u pedijatrijska bolesnika vidi 4. 2, 4. 4 i 5. chronic hepatitis c adult patients pegasys is indicated in combination with other medicinal products, for the treatment of chronic hepatitis c (chc) in patients with compensated liver disease (see sections 4. 2, 4. 4 i 5. virus hepatitisa c (hcv) genotip određene aktivnosti, vidi 4. 2 i 5. paediatric patients 5 years of age and older pegasys in combination with ribavirin is indicated for the treatment of chc in treatment-naïve children and adolescents 5 years of age and older who are positive for serum hcv-rna. pri rješavanju početak liječenja u dječjoj dobi, važno je uzeti u obzir inhibicija rasta, izazvana kombinovanu terapiju. Обратимость inhibicije rasta povjerenja. odluka mora biti donesena na individualnoj osnovi (vidi odjeljak 4.
skuba co-cr sustav perifernog stenta i chromis deep sustav perifernog stenta
medic d.o.o., zagreb - liječenje opstruktivnih bolesti perifernih arterija